Trial Status

NIH SUPPORTED RESEARCH

Dengue virus, HCV-chronic liver Damage

INVRAGEN (INV-DEN-203)

A double-blind, randomized, placebo-controlled, age descending and expansion Phase 2 study to investigate the safety and immunogenicity of a tetravalent […]

AMGEN (20100761)

A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects with Type […]

TAKEDA

A Double-Blind, Randomized, Placebo-Controlled, 5-Arm Titration Study to Evaluate the Efficacy and Safety of TAK-491 When Compared with Valsartan and […]

PFIZER (CV185056)

A Safety and Efficacy Trial Evaluating The Use Of Apixaban In The Treatment Of Symptomatic Deep Vein Thrombosis And Pulmonary […]

PFIZER (CV185057)

A Safety and Efficacy Trial Evaluating The Use Of Apixaban For The Extended Treatment Of Deep Vein Thrombosis And Pulmonary […]
1 2 3 6

Trials Status

Founded by physicians in 2006, LCTC Inc., provides an attractive source for conducting phase III-IV clinical research funded by Pharmaceutical, Biotech Companies, Contract Research Organizations or NIH funded trials.
Latin Clinical Trial Center
1801 Ponce de Leon Ave,
Suite 205, San Juan, PR 00909
787-249-4763 (24/7)
787-985-9911
Fax: 787-982-7100
© 2023 Latin Clinical Trial Center. All Rights Reserved.
chevron-right linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram